June 24, 2010: You are Invited to the
Emerging Therapies: From Microscope to Marketplace
1:45 p.m. to 4:30 p.m. EDT
Webcast begins at 2 p.m. EDT
A reception will follow the broadcast.
Lohrfink Auditorium in the Rafik B. Hariri Building on the campus of Georgetown University 37th and O Streets, NW Washington, DC 20057
The "Emerging Therapies: From Microscope to Marketplace" interactive
Webcast is an educational event about the drug development process. The panel
features members of the scientific community, each involved in a different step
of the drug development pipeline. The panel discussion will feature short
presentations by each speaker followed by questions from the Webcast audience,
the live audience, and the moderator. This discussion will explore the entire
drug development pipeline process, not focus solely on Parkinson's disease,
with a robust discussion about the stages of drug development and how they
Be part of the live audience as the Emerging Therapies interactive Webcast is broadcast online across the country!
Howard Federoff, M.D., Ph.D., Executive Vice President for Health Sciences and
Executive Dean of the School of Medicine at Georgetown University will moderate
James P. Bennett, Jr., M.D., Ph.D.: Chair, Department of Neurology and Founding
Director of the Virginia Commonwealth University Parkinson's Disease and
Movement Disorders Multidisciplinary Research and Clinical Center
Story C. Landis, Ph.D.: Director, National Institute of Neurological Disorders and Stroke, National Institutes of Health
Raymond T. Bartus, Ph.D.: Executive Vice President and Chief Scientific Officer, Ceregene, Inc.
Jackie Hunt Christensen: PAN Minnesota State Coordinator and Clinical Trial Participant
Janet Woodcock, M.D.: Director, Center for Drug Evaluation and Research, Food and Drug Administration